We used flow cytometric and conventional clinicopathologic parameters to analyse the metastatic mode of cancer in 113 stomach cancer patients. Liver metastasis was frequent in cases with intestinal-type cancer, cancer located in the distal stomach, positive venous invasion and aneuploid cancer. Lung and pleural metastasis (excluding nodular lung metastasis), however, were frequent in cases with serosal invasion and diploid cancer. Peritoneal metastasis was frequently seen with tumors located in the proximal or whole stomach, diffuse-type cancer and cancer with serosal invasion. All cases developing bone metastasis were positive for lymph node metastasis. DNA ploidy was partially related to the metastatic mode of stomach cancer, but this was not the sole parameter for predicting metastasis. However, prediction may be possible if based on both DNA ploidy and clinicopathologic parameters, suggesting the possibility of the prophylaxis of recurrence by appropriate postoperative adjuvant therapy.
Introduction
Cancers by nature metastasize; even if primary lesions are excised, many cases recur. Mortality, however, may be reduced if the prophylaxis of metastasis is achieved by anticipating metastatic lesions and providing adequate therapy.
Many studies on the metastatic mode of stomach cancer have been conducted on exclusively morphological factors [1] [2] [3] [4] [5] . Recent investigations using flow cytometric DNA analysis have indicated a close relationship between cancer and clinicopathologic characteristics [6] [7] [8] [9] [10] . However, there are no reports concerning the relationship between DNA ploidy and metastatic mode.
In the present study, we investigated the relationship between DNA ploidy and metastatic mode of gastric cancer. We compared the relationship between conventional clinicopathologic para-*To whom correspondence should be addressed. meters and metastasis with DNA ploidy to determine if ploidy provides an objective parameter for predicting metastasis.
Materials and methods
We selected 113 cases from patients who had undergone gastrectomy at the First Department of Surgery, Hamamatsu University School of Medicine, from 1978 to 1989 and who had been followed after operation until death. We excluded those who had died of other causes and those dying within one month after operation.
Sample preparation and DNA staining
Using 10% formalin-fixed and paraffin-embedded samples, cell suspensions were prepared according to a modification of Hedley's method [11] . Two 50/~m sections were prepared and deparaffinized, then treated in 0.5% pepsin solution (Sigma Chemical Co., St Louis, MO) at 37°C for 60 min. They were then treated in 0.2 M phosphate buffer solution containing 2% 2Na-EDTA at 37°C for 2 h. After shaking with a vortex mixer, cell suspensions were obtained by filtering with 50/~m nylon mesh.
Cells were incubated in 0.1% RNase (Boehringer Mannheim Co., Indianapolis, IN) solutions for 30 min at 37°C. They were stained with 1.12% sodium citrate containing propidium iodide (50 #g ml, Sigma Chemical Co.).
Flow cytometry and DNA index DNA content was measured by an EPICS-PRO-FILE (Culter, USA). 104 nuclei per sample were analysed and histograms recorded. Normal lymph node cells were used as internal standards. The degree of DNA aneuploidy was measured by DNA index, defined as the ratio of peak channel number of the G1/0 tumor cell phase to that of standard cells. Diploidy was defined as those cells having the same DNA index as normal cells, aneuploidy as those other than diploid cells, and multiploidy as those having two or more aneuploid peaks. Those showing coefficient of variation (CV) values of 8% or less were used for DNA analysis.
Clinicopathology
Recurrence patterns were determined by reviewing medical records, including ultrasonography, computerized tomography, cytologic examination, laparotomy and autopsy.
Histologic type was divided into intestinal and diffuse types [12] . Nodal status was judged according to Japanese Guidelines of Gastric Cancer [13] .
Statistical analysis
Data were statistically analysed using the chisquare test and Student's t-test. P values under 0.05 were considered significant. In multivariate analysis using Hayashi's quantification theory [14] , we investigated to what extent clinicopathologic parameters and DNA ploidy affected each metastatic pattern.
Results

DNA ploidy and clinicopathologic characteristics
Among the 113 cases, diploid cancer was seen in 64 (57%), aneuploid cancer in 41 (36%) and multiploid cancer in 8 (7%). For the present study, we considered multiploid cancer as aneuploid cancer. Table 1 shows the relationship between DNA ploidy and clinicopathologic characteristics. A statistical significant difference between diploid and aneuploid cancers was seen in lymphatic invasion, venous invasion and nodal involvement. No statistically significant differences were seen in sex, age, tumor location, histologic type and serosal invasion. In histologic type, however, diploidy was frequently seen in the diffuse type, while aneuploidy was seen in the intestinal type. Table 2 shows the relationship between the metastatic lesions and clinicopathologic parameters, and DNA ploidy. Metastasis to the liver was seen in 42% (47/113), to the lung/pleura in 30% (34/113), to the peritoneum in 53% (60/113) and to the bone in 15% (17/113). Liver metastasis was significantly frequent in the intestinal type, in tumors located in the distal stomach, in cancer associated with venous invasion, and in aneuploid cancer. Lung or pleural metastasis (excluding nodular lung metastasis) was significant in positive serosal invasion and diploid cancer, but no significant difference was seen for other parameters. Metastasis to the peritoneum was significantly frequent in tumors located in the proximal or whole stomach, diffuse type cancer and cancer with serosal invasion. A significant difference in metastasis to the bone was seen for sex and tumor location, while lymph node metastasis was associated with all cases. Tables 3 and 4 show the results of a multivariate analysis of the influence of clinicopathologic parameters and DNA ploidy on the liver or peritoneal metastases. Histology, tumor location, DNA ploidy and venous invasion were shown to be deeply involved in the development of liver metastases, whereas in the case of peritoneal metastases, tumor location, serosal invasion and histology were markedly involved.
Discussion
Many reports have investigated the metastatic mode of gastric cancer in relation to histologic type [1] [2] [3] [4] . Rhomberg and Gruber [4] reported that intestinal-type carcinoma frequently metastasized to the liver, and saw significant peritoneal dissemination in diffuse-type carcinoma. We obtained similar results in this study, as did Duarte and Llanos [1] and Nihei et al. [3] . Kaibala et al. [2] reported that the frequency of liver metastasis is high for papillary adenocarcinoma and poorly differentiated adenocarcinoma of the medullary type, but is low for scirrhous-type gastric cancer which frequently metastasizes to the peritoneum. Noguchi [5] demonstrated the relationship between blood vessel invasion and liver metastasis, and showed that qualitative and quantitative analyses of blood vessel invasion provide a good index for predicting liver metastasis. As described above, metastasis of gastric cancer to the liver or peritoneum is closely related to histologic type or blood vessel invasion. Recently, DNA ploidy has been investigated as an objective parameter for the biological characterization of cancer, including gastric cancer [7] [8] [9] . These studies have shown aneuploid cancer to be frequently associated with lymph node metastasis, liver metastasis and serosal invasion, and to be highly proliferative. Our study showed aneuploid cancer to frequently metastasize to the lymph nodes and liver, corroborating the results of other investigators, while we frequently saw lung and pleural metastasis (excluding nodular lung metastasis) with diploid cancer. Aneuploid cancer has been shown to be highly proliferative and to be closely associated with metastasis and infiltration. It is therefore considered a useful prognostic indicator. In addition to this, however, our results indicate the relationship between DNA ploidy and the site of metastasis.
The present study also showed that the characteristic metastatic mode depends on tumor location. The frequency of liver metastasis was high for tumors located in the distal stomach, while peritoneal and bone metastases were frequent for tumors located in the proximal or whole stomach. On the other hand, it has been reported that differentiated cancer frequently develops in the gastric mucosa with intestinal metaplasia, while undifferentiated cancer with a scirrhous growth 
*P < 0.01; **P < 0.05. Numbers in parentheses indicate individual metastatic rate (%).
pattern develops in the proximal or whole stomach [15, 16] . Accordingly, intestinal-type cancer frequently develops in the distal stomach, while diffuse-type cancer is frequent in the proximal or whole stomach. The difference in this study in metastatic mode depending on tumor location may be due to the influence of histologic type. Esaki et al. [17] have reported a difference in metastatic mode by age, where the frequency of peritoneal involvement was higher in the young than in the elderly, but there was no difference in liver metastasis by age. They ascribed this to the existence of a strong relationship between liver metastasis and histologic type. For appropriate prophylactic therapy leading to a better prognosis, researchers have long sought objective parameters to predict the site of metastasis in gastric cancer, especially liver and peritoneal metastases. In this study, we investigated the metastasis of gastric cancer using DNA ploidy; results show prediction by this parameter only to be impossible, although a partial relationship was noted. However, we believe accurate prediction is possible using characteristics of metastatic mode from both DNA ploidy and conventional clinicopathologic parameters. In addition, better prognosis may be obtained using chemotherapy through hepatic artery catheterization for the prophylaxis of liver metastasis [18] , and thermochemotherapy for peritoneal dissemination [19] . 
